Logo image of HBIO

HARVARD BIOSCIENCE INC (HBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:HBIO - US4169061052 - Common Stock

0.7254 USD
+0 (+0.64%)
Last: 12/24/2025, 7:36:06 PM
0.73 USD
+0 (+0.63%)
After Hours: 12/24/2025, 7:36:06 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
HBIO revenue by date.HBIO revenue by date.
113.3M
-4.71%
112.25M
-0.93%
94.135M
-16.14%
87.618M
-6.92%
93.942M
7.22%
EBITDA
YoY % growth
HBIO ebitda by date.HBIO ebitda by date.
2.87M
-73.96%
9.283M
223.45%
1.781M
-80.81%
8.058M
352.44%
12.291M
52.53%
EBIT
YoY % growth
HBIO ebit by date.HBIO ebit by date.
-4.7M
-238.24%
2.285M
148.62%
-5.376M
-335.27%
-50.184M
-833.48%
3.468M
106.91%
Operating Margin
HBIO operating margin by date.HBIO operating margin by date.
-4.15%2.04%-5.71%-57.28%3.69%
EPS
YoY % growth
HBIO eps by date.HBIO eps by date.
0.12
-52.00%
0.15
25.00%
0.06
-60.00%
0.03
-49.00%
0.10
216.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.04
-40.50%
-0.01
49.00%
0.03
406.00%
0.030.04
14.29%
Revenue
Q2Q % growth
23.562M
-4.05%
21.675M
-0.45%
23.205M
13.47%
23.307M
13.19%
27.234M
15.58%
EBITDA
Q2Q % growth
3.315M
-55.11%
1.377M
4,341.94%
3.111M
25.34%
3.315M
-31.51%
5.202M
56.92%
EBIT
Q2Q % growth
1.122M
392.11%
-765K
52.89%
918K
216.35%
1.122M
357.96%
2.448M
118.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.00
100.00%
0.01-0.01-100.00%
Q2 2025
Q2Q % growth
-0.01 -0.010.001.96%
Q1 2025
Q2Q % growth
-0.01
-150.00%
-0.040.0375.49%
Q4 2024
Q2Q % growth
0.06
50.00%
0.050.0117.65%
Q3 2024
Q2Q % growth
-0.02
-300.00%
0.03-0.05-173.52%
Q2 2024
Q2Q % growth
0.00
-100.00%
0.05-0.05-100.00%
Q1 2024
Q2Q % growth
0.02
-66.67%
0.020.00-15.95%
Q4 2023
Q2Q % growth
0.04 0.05-0.01-21.57%
Q3 2023
Q2Q % growth
0.01
200.00%
0.04-0.03-75.49%
Q2 2023
Q2Q % growth
0.04
-20.00%
0.06-0.02-38.08%
Q1 2023
Q2Q % growth
0.06
50.00%
0.050.0117.65%
Q4 2022
Q2Q % growth
0.04
-50.00%
0.030.0117.66%
Q3 2022
Q2Q % growth
-0.01
-116.67%
0.07-0.08-114.71%
Q2 2022
Q2Q % growth
0.05
-16.67%
0.06-0.01-18.30%
Q1 2022
Q2Q % growth
0.04
-20.00%
0.05-0.01-26.47%
Q4 2021
Q2Q % growth
0.08 0.10-0.02-21.57%
Q3 2021
Q2Q % growth
0.06
50.00%
0.060.00-1.96%
Q2 2021
Q2Q % growth
0.06
20.00%
0.060.00-7.12%
Q1 2021
Q2Q % growth
0.05
600.00%
0.030.0247.07%
Q4 2020
Q2Q % growth
0.08 0.070.0120.66%
Q3 2020
Q2Q % growth
0.04 0.040.0012.04%
Q2 2020
Q2Q % growth
0.05
25.00%
-0.010.06590.20%
Q1 2020
Q2Q % growth
-0.01
-150.00%
0.03-0.04-129.41%
Q4 2019
Q2Q % growth
0.08 0.09-0.01-9.51%
Q3 2019
Q2Q % growth
0.04 0.05-0.01-26.47%
Q2 2019
Q2Q % growth
0.04 0.040.00-1.96%
Q1 2019
Q2Q % growth
0.02 0.03-0.01-41.17%
HBIO Yearly EPS VS EstimatesHBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
20.591M
-6.28%
20.4M191K0.94%
Q2 2025
Q2Q % growth
20.45M
-11.46%
20.808M-358K-1.72%
Q1 2025
Q2Q % growth
21.774M
-11.17%
19.584M2.19M11.18%
Q4 2024
Q2Q % growth
24.556M
-12.78%
24.633M-77K-0.31%
Q3 2024
Q2Q % growth
21.97M
-13.38%
25.806M-3.836M-14.86%
Q2 2024
Q2Q % growth
23.097M
-19.69%
26.928M-3.831M-14.23%
Q1 2024
Q2Q % growth
24.512M
-18.24%
26.309M-1.797M-6.83%
Q4 2023
Q2Q % growth
28.153M
-0.97%
29.692M-1.539M-5.18%
Q3 2023
Q2Q % growth
25.363M
-5.78%
28.584M-3.221M-11.27%
Q2 2023
Q2Q % growth
28.759M
-1.54%
30.24M-1.481M-4.90%
Q1 2023
Q2Q % growth
29.98M
4.17%
29.424M556K1.89%
Q4 2022
Q2Q % growth
28.43M
-14.00%
30.94M-2.51M-8.11%
Q3 2022
Q2Q % growth
26.92M
-9.24%
29.468M-2.548M-8.65%
Q2 2022
Q2Q % growth
29.21M
0.03%
31.096M-1.886M-6.07%
Q1 2022
Q2Q % growth
28.78M
6.63%
29.345M-565K-1.93%
Q4 2021
Q2Q % growth
33.06M
6.71%
33.622M-562K-1.67%
Q3 2021
Q2Q % growth
29.66M
23.38%
28.468M1.192M4.19%
Q2 2021
Q2Q % growth
29.2M
25.27%
28.221M979K3.47%
Q1 2021
Q2Q % growth
26.99M
13.55%
26.245M745K2.84%
Q4 2020
Q2Q % growth
30.98M
0.03%
27.676M3.304M11.94%
Q3 2020
Q2Q % growth
24.04M
-12.33%
24.536M-496K-2.02%
Q2 2020
Q2Q % growth
23.31M
-21.20%
22.639M671K2.96%
Q1 2020
Q2Q % growth
23.77M
-15.71%
28.431M-4.661M-16.39%
Q4 2019
Q2Q % growth
30.97M 32.436M-1.466M-4.52%
Q3 2019
Q2Q % growth
27.42M 29.243M-1.823M-6.23%
Q2 2019
Q2Q % growth
29.58M 29.58M0.00%
Q1 2019
Q2Q % growth
28.2M 28.934M-734K-2.54%
HBIO Yearly Revenue VS EstimatesHBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -12.5% 20% 20%
Revenue0% 0% 0.47% 0.47%